Phocas Financial Corp. Global Blood Therapeutics, Inc. Transaction History

Phocas Financial Corp.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $1.54 Million - $3.22 Million	-36,953 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $1.69 Million - $3.02 Million	36,953 New	36,953 $2.94 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.